UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Zirconia based monoliths used in hydrophilic-interaction chromatography for original selectivity of xanthines

Journal of Chromatography A, 2010-02, Vol.1217 (9), p.1496-1500

2010

Volltextzugriff (PDF)

Nonmolecular Solvents in Separation Methods: Dual Nature of Room Temperature Ionic Liquids

Analytical chemistry (Washington), 2005-07, Vol.77 (13), p.4071-4080

2005

Volltextzugriff (PDF)

Sequence of a complete chicken BG haplotype shows dynamic expansion and contraction of two gene lineages with particular expression patterns

PLoS genetics, 2014-06, Vol.10 (6), p.e1004417-e1004417

2014

Volltextzugriff (PDF)

Synthesis of zirconia monoliths for chromatographic separations

Journal of Chromatography A, 2006-03, Vol.1109 (1), p.19-25

2006

Volltextzugriff (PDF)

Permeability and Release of Decontaminating Agent Used in Cytotoxic Reconstitution Units: Diffusion of Hydrogen Peroxide in IV Bags

Pharmaceutical technology in hospital pharmacy, 2017-03, Vol.2 (1), p.17-21

2017

Volltextzugriff (PDF)

Electrochemical oxidation of 2,4-Dichlorophenoxyacetic acid: Analysis of by-products and improvement of the biodegradability

Chemical engineering journal (Lausanne, Switzerland : 1996), 2012-07, Vol.195-196, p.208-217

2012

Volltextzugriff (PDF)

Abstract 1294: Dual targeting of PDK1 and Aurora A using first-in class OXID-pyridonyl compounds in preclinical models of Ewing sarcoma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1294-1294

2021

Volltextzugriff (PDF)

Combined process for 2,4-Dichlorophenoxyacetic acid treatment—Coupling of an electrochemical system with a biological treatment

Biochemical engineering journal, 2013-01, Vol.70 (15), p.17-22

2013

Volltextzugriff (PDF)

Single radio UHPLC analysis for the quality control of technetium-99m radiolabelled radiopharmaceuticals

Applied radiation and isotopes, 2021-10, Vol.176, p.109874-109874, Article 109874

2021

Volltextzugriff (PDF)

Improvement of the activated sludge treatment by its combination with electro Fenton for the mineralization of sulfamethazine

International biodeterioration & biodegradation, 2014-03, Vol.88, p.29-36

2014

Volltextzugriff (PDF)

Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile

European journal of medicinal chemistry, 2021-12, Vol.226, p.113895, Article 113895

2021

Volltextzugriff (PDF)

Abstract 801: Cellular pharmacokinetics and molecular pharmacodynamics studies of a novel BET inhibitor NHWD870 in sensitive and resistant leukemic cell lines

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.801-801

2018

Volltextzugriff (PDF)

Application of an Environmental Monitoring to Assess the Practices and Control the Risk of Occupational Exposure to Cyclophosphamide in Two Sites of a French Comprehensive Cancer Center

Annals of work exposures and health, 2022-11, Vol.66 (9), p.1215-1223

2022

Volltextzugriff (PDF)

THU-484-Mass spectrometric analysis of serum haptoglobin fucolysation in patients stratified according to fibrosis stages, and the presence of hepatocellular carcinoma

Journal of hepatology, 2019-04, Vol.70 (1), p.e374-e374

2019

Volltextzugriff (PDF)

Phase I-II Open-Label Multicenter Study of Palbociclib + Vemurafenib in BRAF V600MUT Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response Mechanism

Clinical cancer research, 2021-07, Vol.27 (14), p.3876-3883

2021

Volltextzugriff (PDF)

A first-in-class Wiskott-Aldrich syndrome protein activator with anti-tumor activity in hematologic cancers

Haematologica (Roma), 2024-06

2024

Volltextzugriff (PDF)

Abstract 3895: A phase I-II pharmacokinetic drug-drug interaction evaluation of oral palbociclib in combination with vemurafenib in patients suffering metastatic melanoma with BRAF V600 mutated and CDKN2A loss & expression of Rb

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3895-3895

2019

Volltextzugriff (PDF)

Phase I-II open label multicenter study of PD0332991 in BRAF V600mut metastatic melanoma patients harboring CDKN2A loss and RB1 expression and treated with vemurafenib

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9545-9545

2019

Volltextzugriff (PDF)

Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease

Clinics and research in hepatology and gastroenterology, 2020-10, Vol.44 (5), p.681-691

2020

Volltextzugriff (PDF)

Abstract 5044: Pharmacokinetic study of RCHOP protocol in elderly patients with non-Hodgkin lymphoma

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5044-5044

2017

Volltextzugriff (PDF)

Ultra‐fast liquid chromatography method coupled with ultraviolet detection to quantify dimethylsulfoxide, dimethylformamide and dimethylacetamide in short half‐lives radiopharmaceuticals

Journal of labelled compounds & radiopharmaceuticals, 2021-09, Vol.64 (11), p.440-446

2021

Volltextzugriff (PDF)

Abstract 2049: Pharmacokinetic drug-drug interaction: a phase Ib dose escalation study of LY2780301 in combination with weekly paclitaxel

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2049-2049

2016

Volltextzugriff (PDF)

Abstract 2569: Development of potent dual PDK1/AurA kinase inhibitors for Ewing sarcoma therapy

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2569-2569

2022

Volltextzugriff (PDF)

Abstract 1646: Synthesis of [11C]onapristone for clinical investigation

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1646-1646

2014

Volltextzugriff (PDF)

Validation of a population pharmacokinetic (PPK) model for onapristone (ONA) in patients (pts) with cancer: Analysis of 2 clinical trials

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e14099-e14099

2016

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(90)

Publikationsform

Artikel
(93)
Tagungsberichte
(2)

Sprache

Englisch
(88)
Französisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Zirconia based monoliths used in hydrophilic-interaction chromatography for original selectivity of xanthines

Nonmolecular Solvents in Separation Methods: Dual Nature of Room Temperature Ionic Liquids

Sequence of a complete chicken BG haplotype shows dynamic expansion and contraction of two gene lineages with particular expression patterns

Synthesis of zirconia monoliths for chromatographic separations

Permeability and Release of Decontaminating Agent Used in Cytotoxic Reconstitution Units: Diffusion of Hydrogen Peroxide in IV Bags

Electrochemical oxidation of 2,4-Dichlorophenoxyacetic acid: Analysis of by-products and improvement of the biodegradability

Abstract 1294: Dual targeting of PDK1 and Aurora A using first-in class OXID-pyridonyl compounds in preclinical models of Ewing sarcoma

Combined process for 2,4-Dichlorophenoxyacetic acid treatment—Coupling of an electrochemical system with a biological treatment

Single radio UHPLC analysis for the quality control of technetium-99m radiolabelled radiopharmaceuticals

Improvement of the activated sludge treatment by its combination with electro Fenton for the mineralization of sulfamethazine

Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile

Abstract 801: Cellular pharmacokinetics and molecular pharmacodynamics studies of a novel BET inhibitor NHWD870 in sensitive and resistant leukemic cell lines

Application of an Environmental Monitoring to Assess the Practices and Control the Risk of Occupational Exposure to Cyclophosphamide in Two Sites of a French Comprehensive Cancer Center

THU-484-Mass spectrometric analysis of serum haptoglobin fucolysation in patients stratified according to fibrosis stages, and the presence of hepatocellular carcinoma

Phase I-II Open-Label Multicenter Study of Palbociclib + Vemurafenib in BRAF V600MUT Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response Mechanism

A first-in-class Wiskott-Aldrich syndrome protein activator with anti-tumor activity in hematologic cancers

Abstract 3895: A phase I-II pharmacokinetic drug-drug interaction evaluation of oral palbociclib in combination with vemurafenib in patients suffering metastatic melanoma with BRAF V600 mutated and CDKN2A loss & expression of Rb

Phase I-II open label multicenter study of PD0332991 in BRAF V600mut metastatic melanoma patients harboring CDKN2A loss and RB1 expression and treated with vemurafenib

Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease

Abstract 5044: Pharmacokinetic study of RCHOP protocol in elderly patients with non-Hodgkin lymphoma

Ultra‐fast liquid chromatography method coupled with ultraviolet detection to quantify dimethylsulfoxide, dimethylformamide and dimethylacetamide in short half‐lives radiopharmaceuticals

Abstract 2049: Pharmacokinetic drug-drug interaction: a phase Ib dose escalation study of LY2780301 in combination with weekly paclitaxel

Abstract 2569: Development of potent dual PDK1/AurA kinase inhibitors for Ewing sarcoma therapy

Abstract 1646: Synthesis of [11C]onapristone for clinical investigation

Validation of a population pharmacokinetic (PPK) model for onapristone (ONA) in patients (pts) with cancer: Analysis of 2 clinical trials

Suchergebnisse filtern